Incyte Says FDA Issued CRL For Ruxolitinib Extended-release Tablets

RTTNews | 837 days ago
Incyte Says FDA Issued CRL For Ruxolitinib Extended-release Tablets

(RTTNews) - Incyte Corp. (INCY) announced Friday that the U.S. Food and Drug Administration (FDA) has issued a complete response letter for ruxolitinib extended-release (XR) tablets, a JAK1/JAK2 inhibitor, for once-daily (QD) use in the treatment of certain types of myelofibrosis (MF), polycythemia vera (PV) and graft-versus-host disease (GVHD).

The complete response letter states that the FDA cannot approve the application in its present form. The FDA acknowledged that the study submitted in the New Drug Application (NDA) met its objective of bioequivalence based on area under the curve (AUC) parameters but identified additional requirements for approval.

Incyte intends to meet with the FDA to determine appropriate next steps.

The NDA was based on two studies designed to show that ruxolitinib XR tablets are dosage strength proportional and bioequivalent to Jakafi (ruxolitinib) tablets.

read more
Incyte Q4 Adj EPS Misses Estimates, But Revenues Top

Incyte Q4 Adj EPS Misses Estimates, But Revenues Top

Incyte Corp. (INCY) on Tuesday reported net income of $201.10 million or $0.89 per share for the fourth quarter, sharply higher than $28.46 million or $0.13 per share in the prior-year quarter.
RTTNews | 511 days ago
Incyte Q1 Results Top Estimates

Incyte Q1 Results Top Estimates

Incyte Corp. (INCY) on Tuesday reported net income of $161.43 million or $0.72 per share for the first quarter, up from $149.46 million or $0.67 per share in the prior-year quarter.
RTTNews | 1071 days ago
Renewed Selling Pressure Likely For Japan Shares

Renewed Selling Pressure Likely For Japan Shares

The Japanese stock market bounced higher again on Tuesday, one day after ending the two-day winning streak in which it had added just 50 points or 0.2 percent. The Nikkei 225 now sits just beneath the 39,690-point plateau although it's likely to head south again on Wednesday.
RTTNews | 4 minutes ago
KOSPI May Run Out Of Steam On Wednesday

KOSPI May Run Out Of Steam On Wednesday

The South Korea stock market has finished higher in back-to-back sessions, collecting more than 60 points or 1.9 percent along the way. The KOSPI now sits just beneath the 3,115-point plateau although investors may lock in gains on Wednesday.
RTTNews | 19 minutes ago
New Zealand Interest Rate Decision Due On Wednesday

New Zealand Interest Rate Decision Due On Wednesday

The Reserve Bank of New Zealand will wrap up its monetary policy meeting on Wednesday and then announce its decision on interest rates, highlighting a busy day for Asia-Pacific economic activity. The RBNZ is expected to hold its Official Cash Rate steady at 3.25 percent.
RTTNews | 1h 19min ago
U.S. Dollar Higher As Trump Delays Tariff Deadline

U.S. Dollar Higher As Trump Delays Tariff Deadline

The U.S. dollar climbed against its major counterparts in the New York session on Tuesday, as President Donald Trump announced a delay in implementation of tariffs to August 1.
RTTNews | 1h 58min ago
Swiss Market Settles Marginally Up

Swiss Market Settles Marginally Up

Despite spending much of the day's trading session in negative territory, the Switzerland market closed marginally higher on Tuesday thanks to some brisk buying in the final minutes.
RTTNews | 4h 20min ago